Miragen Therapeutics shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Paradigm Biocapital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $66M | 2.9M | 22.75 |
| 2024-06-30 | $38M | 2.9M | 13.01 |
| 2024-03-31 | $88M | 5.0M | 17.51 |
| 2023-12-31 | $104M | 4.8M | 21.78 |
| 2023-09-30 | $57M | 3.7M | 15.34 |
| 2023-06-30 | $58M | 2.4M | 23.79 |
| 2023-03-31 | $53M | 2.1M | 25.44 |
| 2022-12-31 | $51M | 1.8M | 29.21 |
| 2022-09-30 | $34M | 1.6M | 20.51 |
| 2022-06-30 | $15M | 1.3M | 11.57 |
| 2022-03-31 | $23M | 1.3M | 18.49 |
| 2021-12-31 | $24M | 1.2M | 19.77 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors